Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|
MCF 10A | Erlotinib | 0.0033113 | uM | 9 | 1250.00 | 369.45 | 6238.00 | 6354.50 | 0.9817 | 0.9910 |
MCF 10A | 17-AAG | 0.001 | uM | 9 | 1250.00 | 369.45 | 8284.00 | 6354.50 | 1.3036 | 1.1335 |
MCF 10A | 17-AAG | 0.000066069 | uM | 9 | 1250.00 | 369.45 | 7310.00 | 6354.50 | 1.1504 | 1.0694 |
MCF 10A | Linsitinib | 3.1623 | uM | 9 | 1250.00 | 369.45 | 1900.00 | 6354.50 | 0.2990 | 0.4903 |
MCF 10A | Erlotinib | 19.9526 | uM | 9 | 1250.00 | 369.45 | 378.00 | 6354.50 | 0.0595 | 0.0056 |
MCF 10A | Lapatinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 6953.00 | 6354.50 | 1.0942 | 1.0443 |
MCF 10A | Lapatinib | 0.0016596 | uM | 9 | 1250.00 | 369.45 | 8776.00 | 6354.50 | 1.3811 | 1.1637 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 6853.00 | 6354.50 | 1.0784 | 1.0371 | |
MCF 10A | 17-AAG | 0.1 | uM | 9 | 1250.00 | 369.45 | 328.00 | 6354.50 | 0.0516 | -0.0286 |
MCF 10A | Erlotinib | 0.1 | uM | 9 | 1250.00 | 369.45 | 8691.00 | 6354.50 | 1.3677 | 1.1586 |
MCF 10A | Lapatinib | 0.31623 | uM | 9 | 1250.00 | 369.45 | 7746.00 | 6354.50 | 1.2190 | 1.0989 |
MCF 10A | Linsitinib | 0.31623 | uM | 9 | 1250.00 | 369.45 | 5448.00 | 6354.50 | 0.8574 | 0.9264 |
MCF 10A | Lapatinib | 0.01 | uM | 9 | 1250.00 | 369.45 | 6895.00 | 6354.50 | 1.0851 | 1.0402 |
MCF 10A | Linsitinib | 0.031623 | uM | 9 | 1250.00 | 369.45 | 5968.00 | 6354.50 | 0.9392 | 0.9697 |
MCF 10A | Erlotinib | 0.031623 | uM | 9 | 1250.00 | 369.45 | 7349.00 | 6354.50 | 1.1565 | 1.0721 |
MCF 10A | Erlotinib | 1 | uM | 9 | 1250.00 | 369.45 | 486.00 | 6354.50 | 0.0765 | 0.0691 |
MCF 10A | 17-AAG | 0.000302 | uM | 9 | 1250.00 | 369.45 | 5820.00 | 6354.50 | 0.9159 | 0.9576 |
MCF 10A | Lapatinib | 3.1623 | uM | 9 | 1250.00 | 369.45 | 3258.00 | 6354.50 | 0.5127 | 0.6996 |
MCF 10A | 17-AAG | 0.31623 | uM | 9 | 1250.00 | 369.45 | 249.00 | 6354.50 | 0.0392 | -0.0917 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 5744.00 | 6354.50 | 0.9039 | 0.9514 | |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 5867.00 | 6354.50 | 0.9233 | 0.9615 | |
MCF 10A | Linsitinib | 1 | uM | 9 | 1250.00 | 369.45 | 3337.00 | 6354.50 | 0.5251 | 0.7095 |
MCF 10A | Erlotinib | 0.31623 | uM | 9 | 1250.00 | 369.45 | 2395.00 | 6354.50 | 0.3769 | 0.5768 |
MCF 10A | 0 | uM | 9 | 1250.00 | 369.45 | 6487.00 | 6354.50 | 1.0209 | 1.0101 | |
MCF 10A | Linsitinib | 19.9526 | uM | 9 | 1250.00 | 369.45 | 1178.00 | 6354.50 | 0.1854 | 0.3265 |